Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.
Clinical isolates of Pseudomonas aeruginosa from patients with cystic fibrosis were studied in an effort to determine the unique characteristics of the infecting strains and to elucidate the pattern of colonization. Of 413 patients studied, 81% were chronically infected with P. aeruginosa. Patients from whom P. aeruginosa was never or only occasionally isolated were in better clinical condition than the chronically infected patients. Isolates were classified into six morphologic varieties: classic, rough, mucoid, gelatinous, dwarf, and enterobacter. Most patients had two or more of these varieties. Such multiple varieties from the same individual were of the same serotype but often differed in antibiotic susceptibility as determined by both the disk and the minimal inhibitory concentration methods. These differences were apparent when mucoid strains were compared with nonmucoid strains and when nonmucoid strains were compared with one another. Studies of antibiotic susceptibility should be performed on each morphologically different type of P. aeruginosa obtained from patients with cystic fibrosis.
D000293:Adolescent; D000328:Adult; D002228:Carbenicillin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007612:Kanamycin / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D013752:Tetracycline / Q000627:therapeutic use; D013982:Ticarcillin / Q000627:therapeutic use; D013997:Time Factors; D014031:Tobramycin / Q000627:therapeutic use
D005839:Gentamicins; D007612:Kanamycin; D013752:Tetracycline; D013982:Ticarcillin; D002228:Carbenicillin; D014031:Tobramycin